Ablation Technology Market

Ablation Technology Market by Product (Radiofrequency, Laser, Ultrasound (ESWL,HIFU), Microwave, Electrical), Application (Cardiovascular, Cancer, Gynecological, Cosmetic, Pain Management), End User (Hospitals, ASC, Medical spas) - Global Forecast to 2026

Report Code: MD 2738 Aug, 2021, by marketsandmarkets.com

[228 Pages Report] The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed countries and unfavorable regulatory scenario are key factors limiting the growth of this market. Product recalls and therapeutic challenges related to the efficacy of ablation products are key challenges faced by industry players in the global ablation technology market.

Ablation Technology Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the global Ablation Technology Market

The impact of the coronavirus pandemic and the lockdown it triggered is visible in various industries, including the ablation technology market. The overall growth of various sectors has been heavily impacted, specifically in countries with a high incidence rate of COVID-19, such as China, the US, and several European countries (Russia, Italy, and Spain, among others). While industries such as oil and petroleum, aeronautics, and mining are experiencing a steep fall in revenues, the healthcare, biotechnology, and pharmaceutical industries are optimizing this situation to serve the maximum number of patients and healthcare professionals.

The ablation technology market witnessed a loss of business, and the trend continued till late December 2020. Unfavorable changes in regulations and guidelines are hampering the growth of this industry. Major regulatory authorities across the globe (such as CDC, WHO, MHRA, TGA, and EMA) have identified that cancer patients are at greater risk of COVID-19 infection than healthy adults. Thus, screening, diagnostic exams, and surgical procedures are severely restricted or postponed at hospitals and cancer care centers. This is expected to cause disruptions in the ablation technology market.

Ablation Technology Market Dynamics

Driver: increasing demand for minimally invasive/non-invasive procedures

In recent years, the demand for minimally invasive procedures has witnessed a significant increase owing to the advantages offered by these procedures over traditional treatment procedures—fewer operative complications, shorter hospitalization, less pain, smaller & more cosmetic incisions, lower risk of infection, reduced post-operative care, and quicker recovery. Minimally invasive procedures make use of advanced technologies to diagnose and treat various diseases, including cancer. These procedures are used to remove cancer tumors and lymph nodes without scarring. Minimally invasive techniques also assist surgeons in collecting tissues for biopsy and accurate staging studies. This helps surgeons make appropriate and exact cancer treatment plans.

The adoption of minimally invasive techniques also results in significant cost savings. A news article published on March 25, 2015, in JAMA (Journal of the American Medical Association) stated that research conducted by investigators at John Hopkins Medicine, a division of the John Hopkins University (US), showed that American hospitals could collectively save between USD 280 million and USD 340 million a year by performing MIS procedures instead of traditional surgeries. Since ablation is one of the most frequently used minimally invasive techniques for treating tumors, AF, and uterine fibroids, the increasing demand for minimally invasive surgical procedures will increase procedural volumes and contribute to market growth.

Restraint: Strong market positioning of alternative therapies

The availability of effective conventional first-level therapies for the treatment of liver cancer, uterine fibroids, hemorrhagic stroke, and other hemorrhagic conditions is a key restraint to market growth. For instance, therapies such as surgery, chemotherapy, and radiation therapy are preferred in cancer treatment due to the high awareness among individuals about traditional cancer treatments, the low adoption of advanced treatment options (especially in developing countries), and the reluctance among oncologists to shift from conventional treatment options.

Opportunity: Growth potential in emerging economies

Emerging markets, including India, China, Mexico, and Brazil, offer significant growth opportunities in the ablation technology market, owing to factors such as initiatives undertaken by stakeholders across these countries, low regulatory barriers for trade, continuous improvements in the healthcare infrastructure, growing patient population, the relatively low procedural cost for disease treatment (compared to developed countries), less stringent regulatory policies, low competition, and rising healthcare expenditure. Moreover, these regions have reported growth in the incidence and prevalence of lifestyle diseases such as cardiac diseases and cancer

Challenge: Reuse and reprocessing of devices

As per the FDA and EU guidelines, ablation catheters are labeled as single-use devices (SUDs). However, the high per-unit cost and limited reimbursement have led to reprocessing and reuse in hospitals with budget constraints. The cost incurred by a hospital/surgical center for reprocessing and reuse is less than 10% compared to the cost of a new ablation device, reducing the overall procedural cost by around 50%. Germany is among the key European countries that allow the reuse of SUDs (including ablation catheters), provided the devices are reprocessed as per regulatory guidelines. Furthermore, the US has also looked favorably on reprocessing SUDs—according to current FDA clearances, fully leveraging single-use device reprocessing can save US healthcare more than USD 700 million (Source: MPO Summit, 2021)

In terms Application, the cardiovascular treatment segment is expected to account for the largest share of the ablation technology market in 2020.

Based on application, the ablation technology market is classified into major segments—cardiovascular disease treatment, cancer treatment, ophthalmological treatment, pain management, gynecological treatment, urological treatment, orthopedic treatment, cosmetic/aesthetic surgery, and other applications. Rising disease prevalence and technological advancement in this field will boost market growth.

In terms of product segment, radiofrequency ablators segment is expected to account for the largest share during the forecast period.

Based on product, the global ablation technology market is classified into light/laser ablators, radiofrequency ablators, ultrasound ablators, electrical ablators, cryoablation devices, microwave ablators, and hydrothermal ablators/hydromechanical ablators. Each product class is further segmented based on its applications or source of energy.
The large share of radiofrequency ablators segment is attributed to the introduction of novel products by major market players and the increasing adoption of RF ablation technology to treat various conditions, such as cancer, cardiac diseases, and ophthalmic diseases.

In terms of type segment, radiofrequency ablation segment is expected to account for the largest share during the forecast period.

Based on the type of energy source, the global ablation technology market is classified into light/laser, radiofrequency (RF), electrical, ultrasound, microwave, cryotherapy, and hydrothermal / hydromechanical ablation technologies. The lower cost of radiofrequency ablation, its ease of use, and the rising geriatric population fuel the growth of the radiofrequency ablation market.

The hospitals, surgical centers, and ablation centers segment is expected to register the highest CAGR during the forecast period

The ablation technology market, by end user, is segmented into hospitals, surgical centers, and ablation centers, ambulatory surgical centers (ASCs), medical spas & aesthetic centers, and other end users. The increasing incidence of cancer, sports injuries, and cardiac conditions is driving the growth of the ablation technology market for hospitals, surgical centers, and ablation centers segment.

Asia Pacific market is expected to grow at the highest CAGR during the forecast period.

The ablation technology market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2020, Asia Pacific region offered significant opportunities for the growth of the ablation technology market. The market growth in Asia Pacific can be attributed rising incidence and prevalence of cancer and cardiac conditions, technological advancement in ablation product and technology, increasing awareness of minimally invasive techniques and growth opportunities in the emerging markets.

Ablation Technology Market by Region

Key Market Players

The prominent players in the ablation technology market include Medtronic, plc. (Ireland), Johnson & Johnson (US), Abbott (US), and Boston Scientific Corporation (US) and CONMED Corporation (US), AngioDynamics, Inc. (US), AtriCure, Inc. (US), Smith & Nephew plc (UK), Olympus Corporation (Japan), Varian Medical Systems (UK), Stryker (US), Dornier MedTech (Germany), Cynosure (US) and InMode (US).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Billion)

Segments covered

Type,  Product, Application, End User and Region

Geographies covered

Europe, North America, the Asia Pacific, Latin America, and Middle East and Africa

Companies covered

The prominent players in the ablation technology market include Medtronic, plc. (Ireland), Johnson & Johnson (US), Abbott (US), and Boston Scientific Corporation (US) and CONMED Corporation (US), AngioDynamics, Inc. (US), AtriCure, Inc. (US), Smith & Nephew plc (UK), Olympus Corporation (Japan), Varian Medical Systems (UK), Stryker (US), Dornier MedTech (Germany), Cynosure (US) and InMode (US).

This report has segmented the ablation technology market based on application, type, product,  end user, and region.

Global ablation technology market, by Application

  • Cardiovascular Disease Treatment
  • Cancer Treatment
  • Ophthalmologic Treatment
  • Pain Management
  • Gynecological Treatment
  • Urological Treatment
  • Orthopedic Treatment
  • Cosmetic/ Aesthetic Surgery
  • Other Treatments

Global ablation technology market, by Product

  • Radiofrequency Ablators
  • Laser/Light Ablators
  • Ultrasound Ablators
  • Electrical Ablators
  • Cryoablation Devices
  • Microwave Ablators
  • Hydrothermal/Hydromechanical Ablators

Global ablation technology market, by Type

  • Radiofrequency Ablation
  • Laser/Light Ablation
  • Ultrasound Ablation
  • Electrical Ablation
  • Cryoablation
  • Microwave Ablation
  • Hydrothermal/Hydromechanical Ablation

Global ablation technology market, by End User

  • Hospitals, surgical centers, and ablation centers
  • Ambulatory Surgical Centers
  • Medical Spas & Aesthetic clinics
  • Other End Users

Global ablation technology market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East & Africa

Recent Developments

  • In June 2021, Boston Scientific announced the acquisition of the remaining shares of FARAPULSE. The acquisition complemented Boston Scientific’s electrophysiology segment, bringing pulsed-field ablation technology to its portfolio.
  • In April 2021, Olympus Corporation shifted the global headquarters of its Therapeutic Solutions Division from Tokyo to the US for better access to the medical industry and to generate greater growth through stronger business opportunities.
  • In January 2021, AtriCure announced FDA approval for expanding labeling claims for cryo nerve block (cryoNB) therapy to include the treatment of adolescent patients (12-21 years of age).
  • In January 2019, Medtronic entered into a definitive agreement to acquire EPIX Therapeutics, Inc. (EPIX), a private company that designs and manufactures a catheter-based, temperature-controlled cardiac ablation system to treat patients with cardiac arrhythmias (irregular heartbeats), including AF.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 30)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 GEOGRAPHIC SCOPE
           1.3.3 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
           TABLE 1 STANDARD CURRENCY CONVERSION RATES
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA
           FIGURE 1 ABLATION TECHNOLOGY MARKET: RESEARCH DESIGN METHODOLOGY
           2.1.1 SECONDARY RESEARCH
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY RESEARCH
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                               FIGURE 3 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
                               FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    2.2 MARKET SIZE ESTIMATION
           2.2.1 TOTAL MARKET SIZE: ABLATION TECHNOLOGY MARKET
                    2.2.1.1 Bottom-up approach
                               FIGURE 5 MARKET SIZE ESTIMATION: ABLATION TECHNOLOGY MARKET (BOTTOM-UP APPROACH)
                    2.2.1.2 Growth forecast
                               FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           2.2.2 MARKET SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION, AND END USER)
                    FIGURE 7 TOP-DOWN APPROACH
           2.2.3 GEOGRAPHIC MARKET ASSESSMENT (BY REGION & COUNTRY)
           2.2.4 PRIMARY RESEARCH VALIDATION
    2.3 COVID-19 HEALTH ASSESSMENT
    2.4 COVID-19 ECONOMIC ASSESSMENT
    2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
           FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
           FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
    2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE ABLATION TECHNOLOGY MARKET
    2.7 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 10 ABLATION TECHNOLOGY MARKET: DATA TRIANGULATION METHODOLOGY
    2.8 RESEARCH ASSUMPTIONS AND LIMITATIONS
           2.8.1 ASSUMPTIONS FOR THE STUDY
    2.9 RISK ASSESSMENT
           TABLE 2 RISK ASSESSMENT: ABLATION TECHNOLOGY MARKET

3 EXECUTIVE SUMMARY (Page No. - 50)
    FIGURE 11 ABLATION TECHNOLOGY MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    FIGURE 12 ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    FIGURE 13 ABLATION TECHNOLOGY MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 14 ABLATION TECHNOLOGY MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 53)
    4.1 ABLATION TECHNOLOGY MARKET OVERVIEW
           FIGURE 15 EXPANSION OF THE TARGET POPULATION TO DRIVE MARKET GROWTH
    4.2 ABLATION TECHNOLOGY MARKET, BY PRODUCT
           FIGURE 16 RADIOFREQUENCY ABLATORS WILL CONTINUE TO DOMINATE THE ABLATION TECHNOLOGY MARKET BY 2026
    4.3 ABLATION TECHNOLOGY MARKET, BY END USER
           FIGURE 17 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS ARE THE LARGEST END USERS OF ABLATION TECHNOLOGY

5 MARKET OVERVIEW (Page No. - 55)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 18 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing demand for minimally invasive/non-invasive procedures
                    5.2.1.2 The emergence of next-generation ablation products & technologies
                    5.2.1.3 Expansion of the target patient population
                               5.2.1.3.1 Rapid growth in the aging population with a higher risk of targeted diseases
                                            TABLE 3 GERIATRIC POPULATION, BY REGION, 2015 VS 2030
                               5.2.1.3.2 Growing incidence of sports injuries and cancer
                               5.2.1.3.3 Growing prevalence of atrial fibrillation and other cardiac conditions
                    5.2.1.4 The increasing number of hospitals and surgical & ablation centers
           5.2.2 RESTRAINTS
                    5.2.2.1 Insufficient evidence and unfavorable regulatory scenario
                    5.2.2.2 Strong market positioning of alternative therapies
                               TABLE 5 ALTERNATIVE THERAPIES/PROCEDURES TO ABLATION
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth potential in emerging economies
           5.2.4 CHALLENGES
                    5.2.4.1 Product recalls
                    5.2.4.2 Reuse and reprocessing of devices
                    5.2.4.3 Therapeutic challenges and hazardous effects of ablation
    5.3 REGULATORY LANDSCAPE
           TABLE 6 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING ABLATION DEVICES
           5.3.1 NORTH AMERICA
                    5.3.1.1 US
                               TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION
                               TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                               FIGURE 19 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
                    5.3.1.2 Canada
                               FIGURE 20 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
           5.3.2 EUROPE
                     FIGURE 21 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
           5.3.3 ASIA PACIFIC
                    5.3.3.1 Japan
                               TABLE 10 JAPAN: PMDA CLASSIFICATION OF ABLATION DEVICES
                               TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
                    5.3.3.2 China
                               TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.3.3.3 India
                               TABLE 13 INDIA: CDSCO CLASSIFICATION OF ABLATION DEVICES
    5.4 VALUE CHAIN ANALYSIS
           FIGURE 22 VALUE CHAIN ANALYSIS OF THE ABLATION TECHNOLOGY MARKET
    5.5 SUPPLY CHAIN ANALYSIS
           TABLE 14 SUPPLY CHAIN ECOSYSTEM
    5.6 ECOSYSTEM COVERAGE: PARENT MARKET
    5.7 REIMBURSEMENT SCENARIO
           TABLE 15 MEDICAL REIMBURSEMENT CPT CODES FOR MICROWAVE AND RADIOFREQUENCY ABLATION PROCEDURES IN THE US (EFFECTIVE JANUARY 1, 2021)
    5.8 PRICING TREND ANALYSIS
    5.9 TRADE ANALYSIS
           5.9.1 TRADE ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES
                    TABLE 16 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016–2020 (USD BILLION)
    5.1 PORTER’S FIVE FORCE ANALYSIS
           TABLE 17 ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.10.1 THREAT FROM NEW ENTRANTS
           5.10.2 THREAT OF SUBSTITUTES
           5.10.3 BARGAINING POWER OF SUPPLIERS
           5.10.4 BARGAINING POWER OF BUYERS
           5.10.5 INTENSITY OF COMPETITIVE RIVALRY
    5.11 COVID-19 IMPACT ON THE ABLATION TECHNOLOGY MARKET

6 ABLATION TECHNOLOGY MARKET, BY TYPE (Page No. - 83)
    6.1 INTRODUCTION
           TABLE 18 ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
    6.2 RADIOFREQUENCY ABLATION
           6.2.1 THE LOW COST OF RADIOFREQUENCY ABLATION CONTRIBUTES TO MARKET GROWTH
                    TABLE 19 RADIOFREQUENCY ABLATION TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.3 LASER/LIGHT ABLATION
           6.3.1 HIGH EFFICACY AND SAFETY DRIVE THE ADOPTION OF LASER/LIGHT ABLATION
                    TABLE 20 LASER/LIGHT ABLATION TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.4 ULTRASOUND ABLATION
           6.4.1 TECHNOLOGICAL ADVANCEMENTS IN THE ULTRASOUND ABLATION SEGMENT WILL BOOST MARKET GROWTH
                    TABLE 21 ULTRASOUND ABLATION TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.5 ELECTRICAL ABLATION
           6.5.1 THE USE OF ELECTRICAL ABLATION TECHNOLOGY IN CARDIOVASCULAR AND CANCER CONDITIONS WILL BOOST MARKET GROWTH
                    TABLE 22 ELECTRICAL ABLATION TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.6 CRYOABLATION
           6.6.1 INCREASING FOCUS ON COSMETIC SURGERY IS A KEY MARKET GROWTH DRIVER
                    TABLE 23 CRYOABLATION TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.7 MICROWAVE ABLATION
           6.7.1 ADVANTAGES OVER RF ABLATION WILL ENSURE DEMAND FOR MICROWAVE ABLATION
                    TABLE 24 MICROWAVE ABLATION TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.8 HYDROTHERMAL/HYDROMECHANICAL ABLATION
           6.8.1 INCREASING USAGE IN GYNECOLOGY WILL HELP IN MARKET GROWTH
                    TABLE 25 HYDROTHERMAL/HYDROMECHANICAL ABLATION TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION)

7 ABLATION TECHNOLOGY MARKET, BY PRODUCT (Page No. - 92)
    7.1 INTRODUCTION
           TABLE 26 ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
    7.2 RADIOFREQUENCY ABLATORS
           TABLE 27 RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 28 RADIOFREQUENCY ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.2.1 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS
                    7.2.1.1 Clinical advantages of temperature-controlled RF ablators over traditional approaches are driving the market
                               TABLE 29 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.2.2 FLUID-COOLED RADIOFREQUENCY ABLATORS
                    7.2.2.1 Better temperature control as compared to other traditional radiofrequency ablators
                               TABLE 30 FLUID-COOLED RADIOFREQUENCY ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.2.3 ROBOTIC CATHETER MANIPULATION SYSTEMS
                    7.2.3.1 The effectiveness of remote catheter manipulators in AF will propel market growth
                               TABLE 31 ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
    7.3 LASER/LIGHT ABLATORS
           TABLE 32 LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 33 LASER/LIGHT ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.3.1 EXCIMER LASER ABLATORS
                    7.3.1.1 Increasing use of excimer laser ablators in ophthalmological applications is a key driver of the market
                               TABLE 34 EXCIMER LASER ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.3.2 COLD LASER ABLATORS
                    7.3.2.1 Cold laser ablator treatment releases endorphins to support pain management
                               TABLE 35 COLD LASER ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
    7.4 ULTRASOUND ABLATORS
           TABLE 36 ULTRASOUND ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 37 ULTRASOUND ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.4.1 ULTRASONIC SURGICAL ABLATION SYSTEMS
                    7.4.1.1 Ultrasonic surgical ablators dominate the ultrasound ablators market
                               TABLE 38 ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.4.2 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS
                    7.4.2.1 Low procedural times and reduced bleeding support product adoption
                               TABLE 39 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.4.3 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS
                    7.4.3.1 Growing incidence of obesity and diabetes drive the market growth
                               TABLE 40 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.4.4 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS
                    7.4.4.1 A combination of techniques allows for high efficacy
                               TABLE 41 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
    7.5 ELECTRICAL ABLATORS
           TABLE 42 ELECTRICAL ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 43 ELECTRICAL ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.5.1 ARGON PLASMA/BEAM COAGULATORS
                    7.5.1.1 Increasing preference for APC is a key driver of the market
                               TABLE 44 ARGON PLASMA/BEAM COAGULATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.5.2 IRREVERSIBLE ELECTROPORATION ABLATORS
                    7.5.2.1 IRE provides selective targeting and better control
                               TABLE 45 IRREVERSIBLE ELECTROPORATION ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
    7.6 CRYOABLATION DEVICES
           TABLE 46 CRYOABLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 47 CRYOABLATION DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.6.1 TISSUE CONTACT PROBES
                    7.6.1.1 The safety and effectiveness of tissue contact probes have driven their use
                               TABLE 48 TISSUE CONTACT PROBES MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.6.2 TISSUE SPRAY PROBES
                    7.6.2.1 The ability to treat surgically inoperable tumors is driving the use of spray probes
                               TABLE 49 TISSUE SPRAY PROBES MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.6.3 EPIDERMAL & SUBCUTANEOUS CRYOABLATION DEVICES
                    7.6.3.1 Anesthetic properties of epidermal & subcutaneous probes are supporting market growth
                               TABLE 50 EPIDERMAL & SUBCUTANEOUS CRYOABLATION DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
    7.7 MICROWAVE ABLATORS
           TABLE 51 MICROWAVE ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.7.1 MICROWAVE THERMOTHERAPY DEVICES
    7.8 HYDROTHERMAL/HYDROMECHANICAL ABLATORS
           TABLE 52 HYDROTHERMAL/HYDROMECHANICAL ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.8.1 ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES

8 ABLATION TECHNOLOGY MARKET, BY APPLICATION (Page No. - 111)
    8.1 INTRODUCTION
           TABLE 53 ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    8.2 CARDIOVASCULAR DISEASE TREATMENT
           8.2.1 THE GROWTH OF THE TARGET PATIENT POPULATION WILL CONTINUE TO PROPEL THE DEMAND FOR CARDIAC ABLATION DEVICES
                    TABLE 54 ABLATION TECHNOLOGY MARKET FOR CARDIOVASCULAR DISEASE TREATMENT, BY REGION, 2019–2026 (USD MILLION)
    8.3 CANCER TREATMENT
           8.3.1 RISING PREVALENCE OF CANCER TO PROPEL MARKET GROWTH
                    TABLE 55 COUNTRY-WISE CANCER INCIDENCE PER MILLION POPULATION, 2015–2019
           8.3.2 LIVER CANCER
           8.3.3 KIDNEY CANCER
           8.3.4 PROSTATE CANCER
           8.3.5 LUNG CANCER
           8.3.6 BONE METASTASIS
           8.3.7 BREAST CANCER
                    TABLE 56 ABLATION TECHNOLOGY MARKET FOR CANCER TREATMENT, BY REGION, 2019–2026 (USD MILLION)
    8.4 ORTHOPEDIC TREATMENT
           8.4.1 GROWING DISEASE PREVALENCE AND RISING GERIATRIC POPULATION DRIVE DEMAND FOR ABLATION IN ORTHOPEDIC TREATMENT
                    TABLE 57 ABLATION TECHNOLOGY MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2019–2026 (USD MILLION)
    8.5 COSMETIC/AESTHETIC SURGERY
           8.5.1 COSMETIC/AESTHETIC SURGERY TO SEE HIGH GROWTH IN THE COMING YEARS
                    TABLE 58 ABLATION TECHNOLOGY MARKET FOR COSMETIC/AESTHETIC SURGERY, BY REGION, 2019–2026 (USD MILLION)
    8.6 UROLOGICAL TREATMENT
           8.6.1 THE HIGH PREVALENCE OF KIDNEY STONES IS A PROMINENT DRIVER OF MARKET GROWTH
                    TABLE 59 ABLATION TECHNOLOGY MARKET FOR UROLOGICAL TREATMENT, BY REGION, 2019–2026 (USD MILLION)
    8.7 GYNECOLOGICAL TREATMENT
           8.7.1 INCREASING PREVALENCE OF GYNECOLOGICAL CONDITIONS AND REPRODUCTIVE HEALTH CONCERNS TO BOOST MARKET GROWTH
                    TABLE 60 ABLATION TECHNOLOGY MARKET FOR GYNECOLOGICAL TREATMENT, BY REGION, 2019–2026 (USD MILLION)
    8.8 PAIN MANAGEMENT
           8.8.1 RISING DEMAND OF MIS TO HELP SUSTAIN MARKET GROWTH
                    TABLE 61 ABLATION TECHNOLOGY MARKET FOR PAIN MANAGEMENT, BY REGION, 2019–2026 (USD MILLION)
    8.9 OPHTHALMOLOGICAL TREATMENT
           8.9.1 THE RISING PREVALENCE OF VISION DISORDERS AND GROWING POPULATION WILL DRIVE THE MARKET GROWTH
                    TABLE 62 ABLATION TECHNOLOGY MARKET FOR OPHTHALMOLOGICAL TREATMENT, BY REGION, 2019–2026 (USD MILLION)
    8.10 OTHER APPLICATIONS
           TABLE 63 ABLATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)

9 ABLATION TECHNOLOGY MARKET, BY END USER (Page No. - 122)
    9.1 INTRODUCTION
           TABLE 64 ABLATION TECHNOLOGY MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.2 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS
           9.2.1 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS ARE THE MAJOR END USERS OF THE MARKET
                    TABLE 65 ABLATION TECHNOLOGY MARKET FOR HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS, BY REGION, 2019–2026 (USD MILLION)
    9.3 AMBULATORY SURGICAL CENTERS
           9.3.1 PATIENTS ARE INCREASINGLY OPTING FOR AMBULATORY CARE AS A MORE CONVENIENT ALTERNATIVE TO HOSPITAL-BASED OUTPATIENT PROCEDURES
                    TABLE 66 NUMBER OF MEDICARE-CERTIFIED ASCS IN THE US (2013–2018)
                    TABLE 67 ABLATION TECHNOLOGY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2026 (USD MILLION)
    9.4 MEDICAL SPAS & AESTHETIC CLINICS
           9.4.1 MEDICAL SPAS & AESTHETIC CLINICS OFFER ABLATION SERVICES FOR ENHANCING THE BEAUTY AND OVERALL WELLNESS OF THE BODY
                    TABLE 68 ABLATION TECHNOLOGY MARKET FOR MEDICAL SPAS & AESTHETIC CLINICS, BY REGION, 2019–2026 (USD MILLION)
    9.5 OTHER END USERS
           TABLE 69 ABLATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)

10 ABLATION TECHNOLOGY MARKET, BY REGION (Page No. - 127)
     10.1 INTRODUCTION
             TABLE 70 ABLATION TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION)
     10.2 NORTH AMERICA
             FIGURE 23 NORTH AMERICA: ABLATION TECHNOLOGY MARKET SNAPSHOT
             TABLE 71 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 72 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
             TABLE 73 NORTH AMERICA: RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 74 NORTH AMERICA: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 75 NORTH AMERICA: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 76 NORTH AMERICA: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 77 NORTH AMERICA: CRYOABLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 78 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 79 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.1 US
                        10.2.1.1 The rising prevalence of cancer and CVD will propel market growth
                                     TABLE 80 US: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 The high burden of cancer supports market growth
                                     TABLE 81 CANADA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
     10.3 EUROPE
             TABLE 82 EUROPE: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 83 EUROPE: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
             TABLE 84 EUROPE: RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 85 EUROPE: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 86 EUROPE: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 87 EUROPE: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 88 EUROPE: CRYOABLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 89 EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 90 EUROPE: ABLATION TECHNOLOGY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Highly developed healthcare infrastructure and rising disease incidence ensure strong growth prospects
                                     TABLE 91 GERMANY: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.3.2 FRANCE
                        10.3.2.1 Growing geriatric population to support market growth in France
                                     TABLE 92 FRANCE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION
             10.3.3 UK
                        10.3.3.1 Rising geriatric population is supporting the market growth in the UK
                                     TABLE 93 UK: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Rising awareness to support market growth
                                     TABLE 94 ITALY: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Increasing government funding for research to support market growth
                                     TABLE 95 SPAIN: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.3.6 REST OF EUROPE
                                     TABLE 96 ROE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
     10.4 ASIA PACIFIC
             FIGURE 24 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET SNAPSHOT
             TABLE 97 APAC: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 98 APAC: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
             TABLE 99 APAC: RADIOFREQUENCY ABLATORS MARKET, BY TYPE,2019–2026 (USD MILLION)
             TABLE 100 APAC: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 101 APAC: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 102 APAC: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 103 APAC: CRYOABLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 104 APAC: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 105 APAC: ABLATION TECHNOLOGY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Presence of universal healthcare reimbursement scenario and growing geriatric population—key factors driving market growth
                                     TABLE 106 JAPAN: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Increasing patient pool and government initiatives for healthcare development are fueling the market growth
                                     TABLE 107 CHINA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Ongoing modernization and infrastructure development in India to support the market growth
                                     TABLE 108 INDIA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.4.4 AUSTRALIA
                        10.4.4.1 Rising research investments and awareness campaigns are the key factors supporting market growth
                                     TABLE 109 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.4.5 SOUTH KOREA
                        10.4.5.1 Rising R&D and promising clinical trials in the country to positively impact market growth
                                     TABLE 110 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
                                     TABLE 111 ROAPAC: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
     10.5 LATIN AMERICA
             TABLE 112 LATAM: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 113 LATAM: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
             TABLE 114 LATAM: RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 115 LATAM: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 116 LATAM: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 117 LATAM: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 118 LATAM: CRYOABLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 119 LATAM: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
             TABLE 120 LATAM: ABLATION TECHNOLOGY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 Brazil is a key market in Latin America owing to the modernization of healthcare facilities
                                     TABLE 121 BRAZIL: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.5.2 MEXICO
                        10.5.2.1 Availability of advanced care and increasing awareness programs are fueling market growth in Mexico
                                     TABLE 122 MEXICO: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA
                        TABLE 123 ROE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA
           TABLE 124 MEA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 125 MEA: RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 126 MEA: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 127 MEA: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 128 MEA: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 129 MEA: CRYOABLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 130 MEA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 131 MEA: ABLATION TECHNOLOGY MARKET, BY END USER, 2019–2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 167)
     11.1 OVERVIEW
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY KEY ABLATION TECHNOLOGY PROVIDERS
     11.3 REVENUE SHARE ANALYSIS
             FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ABLATION TECHNOLOGY MARKET
     11.4 MARKET SHARE ANALYSIS
             FIGURE 27 MEDTRONIC HELD THE LEADING POSITION IN THE ABLATION TECHNOLOGY MARKET IN 2020
             TABLE 132 ABLATION TECHNOLOGY MARKET: DEGREE OF COMPETITION
     11.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)
             11.5.1 STARS
             11.5.2 PERVASIVE PLAYERS
             11.5.3 EMERGING LEADERS
             11.5.4 PARTICIPANTS
                        FIGURE 28 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION QUADRANT, 2020
     11.6 COMPANY EVALUATION QUADRANT (SMES/START-UPS)
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                        FIGURE 29 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION QUADRANT FOR SMES/START-UPS, 2020
     11.7 COMPETITIVE BENCHMARKING
             FIGURE 30 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ABLATION TECHNOLOGY MARKET
             TABLE 133 COMPANY APPLICATION FOOTPRINT
             TABLE 134 COMPANY REGIONAL FOOTPRINT
     11.8 COMPETITIVE SCENARIO AND TRENDS
             11.8.1 PRODUCT LAUNCHES & APPROVALS
             11.8.2 DEALS
             11.8.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 177)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 
     12.1 KEY PLAYERS
             12.1.1 MEDTRONIC
                        TABLE 135 MEDTRONIC: BUSINESS OVERVIEW
                        FIGURE 31 MEDTRONIC: COMPANY SNAPSHOT
                        TABLE 136 MEDTRONIC: PRODUCT OFFERINGS
             12.1.2 JOHNSON & JOHNSON
                        TABLE 137 JOHNSON & JOHNSON: BUSINESS OVERVIEW
                        FIGURE 32 JOHNSON & JOHNSON: COMPANY SNAPSHOT
                        TABLE 138 JOHNSON & JOHNSON: PRODUCT OFFERINGS
             12.1.3 ABBOTT LABORATORIES
                        TABLE 139 ABBOTT LABORATORIES: BUSINESS OVERVIEW
                        FIGURE 33 ABBOTT LABORATORIES: COMPANY SNAPSHOT
                        TABLE 140 ABBOTT LABORATORIES: PRODUCT OFFERINGS
             12.1.4 BOSTON SCIENTIFIC CORPORATION
                        TABLE 141 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
                        FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
                        TABLE 142 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERINGS
             12.1.5 ANGIODYNAMICS
                        TABLE 143 ANGIODYNAMICS: BUSINESS OVERVIEW
                        FIGURE 35 ANGIODYNAMICS: COMPANY SNAPSHOT
                        TABLE 144 ANGIODYNAMICS: PRODUCT OFFERINGS
             12.1.6 ATRICURE
                        TABLE 145 ATRICURE: BUSINESS OVERVIEW
                        FIGURE 36 ATRICURE: COMPANY SNAPSHOT
                        TABLE 146 ATRICURE: PRODUCT OFFERINGS
             12.1.7 CONMED CORPORATION
                        TABLE 147 CONMED: BUSINESS OVERVIEW
                        FIGURE 37 CONMED CORPORATION: COMPANY SNAPSHOT
                        TABLE 148 CONMED: PRODUCT OFFERINGS
             12.1.8 OLYMPUS CORPORATION
                        TABLE 149 OLYMPUS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT
                        TABLE 150 OLYMPUS CORPORATION: PRODUCT OFFERINGS
             12.1.9 SMITH & NEPHEW
                        TABLE 151 SMITH & NEPHEW: BUSINESS OVERVIEW
                        FIGURE 39 SMITH & NEPHEW: COMPANY SNAPSHOT
                        TABLE 152 SMITH & NEPHEW: PRODUCT OFFERINGS
             12.1.10 STRYKER CORPORATION
                        TABLE 153 STRYKER: BUSINESS OVERVIEW
                        FIGURE 40 STRYKER CORPORATION: COMPANY SNAPSHOT
                        TABLE 154 STRYKER: PRODUCT OFFERINGS
             12.1.11 DORNIER MEDTECH
                        TABLE 155 DORNIER MEDTECH: BUSINESS OVERVIEW
                        TABLE 156 DORNIER MEDTECH: PRODUCT OFFERINGS
             12.1.12 CYNOSURE
                        TABLE 157 CYNOSURE: BUSINESS OVERVIEW
                        TABLE 158 CYNOSURE: PRODUCT OFFERINGS
             12.1.13 VARIAN MEDICAL SYSTEMS
                        TABLE 159 VARIAN MEDICAL SYSTEMS: BUSINESS OVERVIEW
                        FIGURE 41 VARIAN MEDICAL SYSTEMS.: COMPANY SNAPSHOT
                        TABLE 160 VARIAN MEDICAL SYSTEMS: PRODUCT OFFERINGS
             12.1.14 INMODE
                        TABLE 161 INMODE: BUSINESS OVERVIEW
                        FIGURE 42 INMODE: COMPANY SNAPSHOT
                        TABLE 162 INMODE: PRODUCT OFFERINGS
     12.2 OTHER COMPANIES
             12.2.1 EDAP TMS
             12.2.2 LUMENIS
             12.2.3 ARTHREX
             12.2.4 ICECURE
             12.2.5 MERIT MEDICAL
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 

13 APPENDIX (Page No. - 219)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the ablation technology market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Primary research was conducted after acquiring extensive knowledge about the global ablation technology market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as hospitals, research universities, academic institutions, and government institutions, among others) and supply-side respondents (such as presidents, CEOs, vice presidents, directors, general managers, heads of business units, and senior managers) across five major geographies, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East, and Africa. Approximately 30% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 70%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Ablation Technology Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

A detailed market estimation approach was followed to estimate and validate the size of the global ablation technology market and other dependent submarkets.

  • Key players in the global ablation technology market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • The research methodology included the study of the annual and quarterly financial reports & regulatory filings of major market players as well as interviews with industry experts (such as CEOs, VPs, directors, and marketing executives) for detailed insights (both qualitative and quantitative trends) on the ablation technology market. 
  • All percentage shares, splits, and breakdowns for the global ablation technology market were determined by using secondary sources and verified through primary sources.
  • All the key macro indicators affecting the revenue growth of the market segments and sub-segments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the validated and verified quantitative & qualitative data.
  • The gathered market data was consolidated and added to detailed inputs, analyzed, and presented in this report.

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Ablation Technology Market Size, and Share

Data Triangulation:

After arriving at the overall size of the global ablation technology market through the above-mentioned methodology, this market was split into several segments and sub-segments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and sub-segments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both the demand- and supply-side participants.

Report Objectives:

  • To define, describe, and forecast the ablation technology market based on type, product, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the global ablation technology market (such as drivers, restraints, challenges, opportunities, and regulatory landscape, among others)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global ablation technology market
  • To analyze the opportunities in the global ablation technology market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile key global players and comprehensively analyze their market shares and core competencies
  • To provide a five-year forecast for various market segments in terms of revenue with respect to five main regions, namely, North America (includes the US and Canada), Europe (includes Germany, the UK, France, Italy, and Spain), Asia Pacific (includes Japan, China, India, Australia, and South Korea), Latin America (includes Brazil and Mexico), and the Middle East & Africa
  • To track and analyze competitive developments such as product launches; expansions, and mergers and acquisitions; and research and development activities in the ablation technology market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the global ablation technology market report:

Product analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company information

  • Detailed analysis and profiling of additional market players (up to five)

Geographic analysis

  • Further breakdown of the Rest of Europe ablation technology market into Belgium, Austria, Denmark, Greece, Poland, and Russia, among other countries
  • Further breakdown of the Rest of Asia Pacific ablation technology market into New Zealand, Vietnam, Philippines, Singapore, Malaysia, Thailand, and Indonesia, among other countries
  • Further breakdown of the Rest of Latin America ablation technology market into Argentina and Colombia, among other countries
COVID-19

Get in-depth analysis of the COVID-19 impact on the Ablation Technology Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Ablation Technology Market

Request For Special Pricing
Report Code
MD 2738
Published ON
Aug, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Ablation Technology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved